It is widely accepted that cancer cells become refractory to TGFβ-mediated growth suppression and become more aggressive upon chronic exposure to TGFβ, once the cancer acquires mesenchymal properties [3]; this favors a TGFβ-enriched microenvironment. The gene discussed is TGFB1; the disease is cancer.